Comparative Effectiveness of Remdesivir in Hospitalized COVID-19 Patients: A Retrospective Cohort Study From the Pre-vaccination and Omicron Eras.

Cureus · 2025 · PMC12332229 · PMID 40786399

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Although in-hospital mortality was not significantly lower in the remdesivir group, a favorable trend emerged in the 2023 cohort, suggesting a potential synergistic effect between remdesivir, early intervention, and improved supportive care [ 11 - 13 ].

also in 907 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.